Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antiretrovirals
antiretrovirals
Gilead, Merck say HIV combo could be weekly, oral HIV drug
Pharmaphorum
Mon, 10/21/24 - 09:35 am
Gilead Sciences
Merck
HIV
antiretrovirals
clinical trials
islatravir
Sunleca
Antiretroviral Therapy's Positive Impact On Global Public Health Faces Challenges Moving Forward
Forbes
Mon, 08/12/19 - 10:28 am
HIV
Public Health
antiretrovirals
Gilead, Aelix ally to trial HIV-suppressing combination
Fierce Biotech
Thu, 10/18/18 - 11:20 am
Gilead Sciences
Aelix Therapeutics
vaccines
antiretrovirals
HIV
Why Payers Sometimes Restrict Access To Single Tablet Regimens For HIV Patients
Forbes
Mon, 10/1/18 - 09:45 am
HIV
antiretrovirals
payers
HIV Drug Cocktail Protect Hearts of Children With Virus
Bloomberg
Tue, 04/23/13 - 10:44 am
HIV
antiretrovirals
Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment
PR-USA.net
Mon, 01/31/11 - 07:57 am
Mylan
Matrixx
HIV
antiretrovirals
Tibotec
TMC278
Aurobindo Pharma receives tentative approval for its New Drug Application (NDA) Efavirenz Tablets 100mg
prodomain, com, India
Sat, 12/20/08 - 02:17 pm
Efavirenz
Aurobindo
antiretrovirals